Abstract: Poster Presentations |

Association of troponin I concentrations with outcomes in sepsis FREE TO VIEW

Praveen Mannam, MD*; Veena S. Devarakonda, MD; Eric T. Wittbrodt, PharmD; Michael Sherman, MD; Siva K. Ramachandran, MD
Author and Funding Information

Drexel University College of Medicine, Philadelphia, PA


Chest. 2004;126(4_MeetingAbstracts):865S. doi:10.1378/chest.126.4_MeetingAbstracts.865S
Text Size: A A A
Published online


PURPOSE:  Troponin I is a sensitive test used for the diagnosis of acute coronary syndromes. Sepsis is a leading cause of death in intensive care units (ICU), characterized by diffuse end organ damage including myocardial dysfunction. The clinical significance of elevated troponin I concentrations in sepsis is not clearly understood. We retrospectively examined the association of troponin I concentration with selected outcomes in patients who were diagnosed with sepsis.

METHODS:  The medical records of 24 patients admitted with documented troponin I concentrations within 10 days after onset of sepsis were reviewed. Patients with acute coronary syndrome, cardiac surgery, pulmonary embolus, or cerebrovascular accident were excluded. Continuous data were compared using Mann-Whitney U test. Correlation of selected outcomes was calculated using the Spearman rank correlation test. Mortality was compared using Kaplan-Meier analysis with log rank test.

RESULTS:  Mean age was similar between groups of patients with normal troponin I (<1ng/ml, n=13, group 1) and elevated troponin I (>1ng/ml, n=11, group 2). Patients in group 2 were more ill (mean APACHE II score 20.6 vs. 13.5, p=0.01), required increased use of pressors (pressor-days 9.9 vs. 1, p=0.006), and experienced longer duration of mechanical ventilation (12 vs. 2 days, p=0.002). Mortality was significantly higher in group 2 (45.4% vs. 7.7%, log rank test = 4.218, p<0.04). The degree of elevation of troponin I concentrations correlated with APACHE II scores (r= 0.66; 95% CI, 0.34-0.84, p=0.0004). Patients in group 2 experienced a statistically nonsignificant trend toward longer ICU stay (16.3 vs. 5.3 days, p=0.082).

CONCLUSION:  Elevated troponin I concentrations are associated with greater severity of illness, increased 28-day mortality, and longer duration of mechanical ventilation and vasopressor use in patients with sepsis.

CLINICAL IMPLICATIONS:  The presence of elevated troponin I is a function of both the severity of sepsis and also the extent of myocardial injury, both of which contribute to poorer outcomes in such patients. Troponin I concentration may serve as a useful marker in identifying patients with sepsis at increased risk of mortality.

Table-Summary of Troponin I in Sepsis Study

Age (y)Troponin I (ng/ml)ICU Stay (Days)Ventilator daysPressor- dayscAPACHE II Score28-day MortalityGroup 1a n=13Mean± SD Median62.3±14.5 630.22±0.27 0.105.3±5.7 41.5±2.8 01±1.8 013.54±4.54 131/13(7.69%)Group 2b n=11Mean± SD Median63±19.4 6712.81±22.76 4.816.3±17.4 1012.4±11.4 108±9.8 620.64±6.84 205/11(45.45%)p value0.7943<0.00010.0820.00160.02350.0108p<0.04a

Group 1: Troponin I<1 ng/ml

DISCLOSURE:  P. Mannam, None.

Wednesday, October 27, 2004

12:30 PM- 2:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543